Volume | 7,411 |
|
|||||
News | - | ||||||
Day High | 37.92 | Low High |
|||||
Day Low | 37.35 |
Company Name | Stock Ticker Symbol | Market | Type |
---|---|---|---|
Taro Pharmaceutical Industries Ltd | TARO | NYSE | Common Stock |
Open Price | Low Price | High Price | Close Price | Prev Close |
---|---|---|---|---|
37.92 | 37.35 | 37.92 | 37.78 |
Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
---|---|---|---|---|---|
325 | 7,411 | $ 37.54 | $ 278,175 | - | 22.89 - 42.22 |
Last Trade Time | Type | Quantity | Stock Price | Currency |
---|---|---|---|---|
13:53:01 | 14 | $ 37.59 | USD |
Taro Pharmaceutical Industries Ltd Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
1.42B | 37.58M | - | 572.95M | 25.45M | 0.68 | 55.38 |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
Taro Pharmaceutical Indu... News
Loading Messages....
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical TARO Price Data
Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 39.04 | 39.26 | 37.35 | 38.14 | 21,496 | -1.38 | -3.53% |
1 Month | 38.78 | 40.80 | 37.17 | 38.69 | 27,906 | -1.12 | -2.89% |
3 Months | 36.71 | 40.80 | 35.29 | 37.85 | 42,707 | 0.95 | 2.59% |
6 Months | 24.26 | 42.22 | 22.89 | 36.46 | 47,774 | 13.40 | 55.23% |
1 Year | 30.70 | 42.22 | 22.89 | 34.65 | 32,092 | 6.96 | 22.67% |
3 Years | 55.00 | 80.00 | 22.89 | 48.67 | 26,212 | -17.34 | -31.53% |
5 Years | 98.00 | 109.42 | 22.89 | 70.59 | 37,522 | -60.34 | -61.57% |
Taro Pharmaceutical Indu... Description
Taro Pharmaceutical Industries Ltd produces, researches, develops, and markets pharmaceutical products. Its primary focus includes semi-solids formulations, such as creams and ointments and other dosage forms such as liquids, capsules, and tablets. The company is engaged in the dermatological and topical, cardiovascular, neuropsychiatric, and anti-inflammatory therapeutic categories. Geographically, it derives a majority of revenue from the United States and also has a presence in Canada, Israel, and Other Countries. |